期刊文献+

PTEN: a default gate-keeping tumor suppressor with a versatile tail 被引量:7

PTEN: a default gate-keeping tumor suppressor with a versatile tail
下载PDF
导出
摘要 The tumor suppressor PTEN controls a variety of biological processes including cell proliferation, growth, migration, and death. As a master cellular regulator, PTEN itself is also subjected to deliberated regulation to ensure its proper function. Defects in PTEN regulation have a profound impact on carcinogenesis. In this review, we briefly discuss recent advances concerning PTEN regulation and how such knowledge facilitates our understanding and further exploration of PTEN biology. The carboxyl-tail of PTEN, which appears to be associated with multiple types of posttranslational regulation, will be under detailed scrutiny. Further, a comparative analysis of PTEN and p53 suggests while p53 needs to be activated to suppress tumorigenesis (a dormant gatekeeper), PTEN is probably a constitutive surveillant against cancer development, thus a default gatekeeper.
机构地区 Cell Biology Program
出处 《Cell Research》 SCIE CAS CSCD 2008年第8期807-816,共10页 细胞研究(英文版)
关键词 PTEN tumor suppressor posttranslational regulation UBIQUITINATION p53 肿瘤抑制 遗传学 基因研究 细胞表达
  • 相关文献

参考文献87

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947.
  • 2Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362.
  • 3Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129.
  • 4Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95:29-39.
  • 5Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and turnout suppression. Nat Genet 1998; 19:348-355.
  • 6Sun H, Lesche R, Li DM, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA 1999; 96:6199-6204.
  • 7Podsypanina K, Ellenson LH, Nemes A, et al. Mutation of Pten/Mmac 1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 1999; 96:1563-1568.
  • 8Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/ MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999; 91:1922-1932.
  • 9Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22:2954-2963.
  • 10Liaw D, Marsh D J, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome, Nat Genet 1997; 16:64-67.

同被引文献46

  • 1LAN Fei1 & SHI Yang 2 1 Department of Biology, Constellation Pharmaceuticals, 148 Sidney Street, Cambridge, MA 02139, USA 2 Department of Pathology, Harvard Medical School, 77 Ave Louise Pasteur, Boston MA, 02115, USA.Epigenetic regulation: methylation of histone and non-histone proteins[J].Science China(Life Sciences),2009,52(4):311-322. 被引量:27
  • 2B.A. Bohn,S. Mina,A. Krohn,R. Simon,M. Kluth,S. Harasimowicz,A. Quaas,M. Bockhorn,J.R. Izbicki,G. Sauter,A. Marx,P.R. Stahl.Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer[J]. Human Pathology . 2013 (8)
  • 3Jueng Soo You,Peter A. Jones.Cancer Genetics and Epigenetics: Two Sides of the Same Coin?[J]. Cancer Cell . 2012 (1)
  • 4Binqiang Tian,Zhiping Wang,Yingmei Zhao,Degui Wang,Yonggang Li,Li Ma,Xiaoming Li,Jing Li,Nan Xiao,Junqiang Tian,Ronald Rodriguez.Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model[J]. Cancer Letters . 2008 (2)
  • 5Shishir Shishodia,Hesham M. Amin,Raymond Lai,Bharat B. Aggarwal.Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma[J]. Biochemical Pharmacology . 2005 (5)
  • 6Hadas Dvory-Sobol,Efrat Cohen-Noyman,Diana Kazanov,Arie Figer,Shlomo Birkenfeld,Liora Madar-Shapiro,Robert Benamouzig,Nadir Arber.Celecoxib leads to G 2 /M arrest by induction of p 21 and down-regulation of cyclin B1 expression in a p 53-independent manner[J]. European Journal of Cancer . 2005 (3)
  • 7Kristin A. Waite,Charis Eng.Protean PTEN: Form and Function[J]. The American Journal of Human Genetics . 2002 (4)
  • 8Michael M. Gottesman.MECHANISMS OF CANCER DRUG RESISTANCE[J]. Annual Review of Medicine . 2002
  • 9PUNEET SINDHWANI,JAMES A. HAMPTON,MIRZA M. BAIG,RICK KECK,STEVEN H. SELMAN.CURCUMIN PREVENTS INTRAVESICAL TUMOR IMPLANTATION OF THE MBT-2 TUMOR CELL LINE IN C3H MICE[J]. The Journal of Urology . 2001 (4)
  • 10Kun-Tu Yeh,Jan-Gowth Chang,Yi-Jen Chen,Shou-Tung Chen,Shi-Yau Yu,Mu-Ching Shih,Liuh-L Perng,Jyh-Chwan Wang,Matty Tsai,Chih-Peng Chang.Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Hepatocellular Carcinoma[J]. Cancer Investigation . 2000 (2)

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部